Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor

Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor

Mutasem Elfalah,1 Saif Aldeen AlRyalat,1 Mario Damiano Toro,2– 4 Robert Rejdak,4 Sandrine Zweifel,3 Rashed Nazzal,5 Mohammed Abu-Ameerh,1 Osama Ababneh,1 Almutez Gharaibeh,1 Zuhair Sharif,1 Jehad Meqbil,1 Mo’ath AlShawabkeh,1 Amal Alwreikat,6 Muawyah Al Bdour,1 Maysa Al-Hussaini,...

Full description

Bibliographic Details
Main Authors: Elfalah M, AlRyalat SA, Toro MD, Rejdak R, Zweifel S, Nazzal R, Abu-Ameerh M, Ababneh O, Gharaibeh A, Sharif Z, Meqbil J, AlShawabkeh M, Alwreikat A, Al Bdour M, Al-Hussaini M, Yousef YA
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:Clinical Ophthalmology
Subjects:
covid-19 lockdown
covid-19 pandemic
ethics
intravitreal injection
macular edema.
Online Access:https://www.dovepress.com/delayed-intravitreal-anti-vegf-therapy-for-patients-during-the-covid-1-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/delayed-intravitreal-anti-vegf-therapy-for-patients-during-the-covid-1-peer-reviewed-article-OPTH

Similar Items